Allan Svendsen did his master of science in biochemistry and protein chemistry in 1985 from the University of Copenhagen, Denmark. From 1986 to 2008, he worked as a research scientist at Nordisk Gentofte A/S and Novo Nordisk A/S. Later, he joined Novo Nordisk A/S and Novozymes A/S as a science manager and then became senior science manager at Novozymes A/S, where since 2008, he has been science director. His research area is protein engineering in general, but he has been working especially with insulin, proteases, oxidases, amylases, and lipases. His work has been within HPLC analysis, purification, downstream processing, and assay development. Lipase protein engineering and structural computer analysis and design of variants have been a central area for around 26 years. Dr. Svendsen has worked as a coordinator for a lipase protein engineering project at the Nordic Industrial Foundation. He was the organizer and coordinator of an EU-funded nanotechnology project, “Lipid–Lipase Structure Function Relationship: Novel Methods for Studying Interfacial Enzyme Actions and Relation to Structure of Self-Assembled Lipid Nanostructures,” and the co-organizer of another EU-funded nanotechnology project, “BIO-SCOPE.” He has supervised many master’s students and a few PhD students and has acted as censor for a number of PhD and master’s theses defenses. He has reviewed manuscripts for various journals, co-edited a special issue of Colloids and Surface B: Biointerfaces (2001), and edited Enzyme Functionality: Design, Engineering and Screening (2002 and 2003 editions) published by Marcel Dekker, USA. He has published more than 100 articles in refereed international journals, has more than 90 patents and patent applications, and has made more than 30 presentations at scientific conferences.
